BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 31435169)

  • 1. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.
    Clarke WT; Feuerstein JD
    World J Gastroenterol; 2019 Aug; 25(30):4148-4157. PubMed ID: 31435169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in colorectal cancer screening in inflammatory bowel disease.
    Clarke WT; Feuerstein JD
    Curr Opin Gastroenterol; 2018 Jul; 34(4):208-216. PubMed ID: 29771698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the quality of endoscopy in inflammatory bowel disease: focus on surveillance and management of colorectal dysplasia using interactive image- and video-based teaching.
    Kaltenbach TR; Soetikno RM; DeVivo R; Laine LA; Barkun A; McQuaid KR;
    Gastrointest Endosc; 2017 Dec; 86(6):1107-1117.e1. PubMed ID: 28818507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
    Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
    Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal Cancer Screening in Inflammatory Bowel Disease.
    Sengupta N; Yee E; Feuerstein JD
    Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a consensus on endoscopic surveillance of patients with colonic inflammatory bowel disease.
    Shergill AK; Farraye FA
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):469-81. PubMed ID: 24975537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West).
    Soetikno R; Kaltenbach T; McQuaid KR; Subramanian V; Kumar R; Barkun AN; Laine L
    Dig Endosc; 2016 Apr; 28(3):266-73. PubMed ID: 26866420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromoendoscopy for Dysplasia Surveillance in Inflammatory Bowel Disease.
    Flynn AD; Valentine JF
    Inflamm Bowel Dis; 2018 Jun; 24(7):1440-1452. PubMed ID: 29668929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An updated approach to dysplasia in IBD.
    Rubin DT
    J Gastrointest Surg; 2008 Dec; 12(12):2153-6. PubMed ID: 18766409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
    Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
    Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
    [No Abstract]   [Full Text] [Related]  

  • 12. Dysplasia and colorectal cancer surveillance in inflammatory bowel disease.
    Pulusu SSR; Lawrance IC
    Expert Rev Gastroenterol Hepatol; 2017 Aug; 11(8):711-722. PubMed ID: 28475382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy.
    Deepak P; Hanson GJ; Fletcher JG; Tremaine WJ; Pardi DS; Kisiel JB; Schroeder KW; Wong Kee Song LM; Harmsen WS; Loftus EV; Bruining DH
    Gastrointest Endosc; 2016 May; 83(5):1005-12. PubMed ID: 26408903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of nonpolypoid (flat and depressed) colorectal neoplasms in screening for CRC in patients with IBD.
    Rutter MD
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):327-35. PubMed ID: 24975524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic detection and resection of dysplasia in inflammatory bowel disease-techniques with videos.
    Khalid S; Abbass A; Khetpal N; Shen B; Navaneethan U
    Int J Colorectal Dis; 2019 Apr; 34(4):569-580. PubMed ID: 30854573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre randomised controlled trial on virtual chromoendoscopy in the detection of neoplasia during colitis surveillance high-definition colonoscopy (the VIRTUOSO trial).
    Kandiah K; Subramaniam S; Thayalasekaran S; Chedgy FJ; Longcroft-Wheaton G; Fogg C; Brown JF; Smith SC; Iacucci M; Bhandari P
    Gut; 2021 Sep; 70(9):1684-1690. PubMed ID: 33214162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Premalignant and malignant changes in idiopathic inflammatory bowel disease].
    Knezević-Usaj S; Panisić M; Tarabar D; Cuk V; Brajuković G; Petrović M
    Acta Chir Iugosl; 2000; 47(1-2):43-50. PubMed ID: 10953365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance strategies in inflammatory bowel disease.
    Schmidt C; Bielecki C; Felber J; Stallmach A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):189-201. PubMed ID: 20485256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopy/surveillance in inflammatory bowel disease.
    Ahmadi AA; Polyak S
    Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
    Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
    Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.